The role of induction therapy before autologous stem cell transplantation in low disease burden AL amyloidosis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of induction therapy before autologous stem cell transplantation in low disease burden AL amyloidosis patients

Published:2020-10-21 Issue:2 Volume:28 Page:75-83
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Huang Xianghua¹,Ren Guisheng¹,Chen Wencui¹,Guo Jinzhou¹,Zhao Liang¹,Zeng Caihong¹,Ge Yongchun¹,Liu Zhihong¹

Affiliation:

1. National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China

Funder

Key Research and Development

Jiangsu Province - Social Development Projects

Jiangsu Natural Science Foundation

National Key Research and Development Program ‘Stem Cell and Transformation Research

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2020.1835635

Reference38 articles.

1. Systemic immunoglobulin light chain amyloidosis

2. Amyloidosis: Pathogenesis and New Therapeutic Options

3. Transplantation vs. conventional-dose therapy for amyloidosis

4. High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review

5. Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors in Chinese patients with immunoglobulin light chain amyloidosis: a scoping review and meta-analysis;Annals of Medicine;2024-08-12

2. HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients;eJHaem;2024-06-17

3. Acute kidney injury during autologous stem cell transplantation in light chain amyloidosis with kidney involvement and their impact on prognosis;Bone Marrow Transplantation;2024-04-24

4. Risk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation;Bone Marrow Transplantation;2023-12-26

5. The Clinical Characteristics of Immunoglobulin Light Chain Amyloidosis in the Chinese Population: A Systematic Scoping Review;Hemato;2022-12-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3